ArticleMultiple sclerosis (Houndmills, Basingstoke, England)2022

Long-term treatment with anti-CD20 monoclonal antibodies is untenable because of risk: YES.

Chiara Zecca et al.PubMed ↗Publisher ↗

No numbers read from the abstract.